Issue 4, 2016

The Ireland–Claisen rearrangement strategy towards the synthesis of the schizophrenia drug, (+)-asenapine

Abstract

(±)-Asenapine, sold in the market as Saphris/Sycrest for the treatment of bipolar disorders, is synthesized in an optically pure form involving an Ireland–Claisen rearrangement as the key step. This approach allows access to all diastereomers.

Graphical abstract: The Ireland–Claisen rearrangement strategy towards the synthesis of the schizophrenia drug, (+)-asenapine

Supplementary files

Article information

Article type
Paper
Submitted
01 Oct 2015
Accepted
27 Nov 2015
First published
27 Nov 2015

Org. Biomol. Chem., 2016,14, 1332-1337

Author version available

The Ireland–Claisen rearrangement strategy towards the synthesis of the schizophrenia drug, (+)-asenapine

R. R. Anugu, P. S. Mainkar, B. Sridhar and S. Chandrasekhar, Org. Biomol. Chem., 2016, 14, 1332 DOI: 10.1039/C5OB02047F

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements